Testosterone Gel
Product Images NDC 45802-754

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Testosterone (NDC 45802-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

An instructional illustration showing application areas for testosterone gel on the human body. Shaded regions highlight the left and right upper arms as the intended topical application sites.*

FDA Label Image

Structure (Image 07)

Chemical structure of testosterone is shown, including its molecular formula C19H28O2 and molecular weight 288.42. The diagram depicts the steroid backbone with hydroxyl and ketone functional groups characteristic of testosterone.*

FDA Label Image

Figure-2 (Image 08)

A line graph showing total testosterone (ng/dL) over time (hours) with two data series: Upper Arms/Shoulders and Rotation of Abdomen and Upper Arms/Shoulders. Both lines present fluctuations and error bars from 0 to 24 hours post-application, illustrating testosterone levels following topical gel application at different body sites.*

FDA Label Image

Figure-3 (Image 02)

A line graph showing mean total testosterone levels (ng/dl) over 24 hours on day 112 for different doses of testosterone gel 1.62% compared to a placebo. It includes error bars for standard deviation and marks the normal testosterone range between 300 and 1000 ng/dl with upper and lower bound lines.*

FDA Label Image

Figure-4 (Image 03)

A line graph depicting mean total testosterone levels (ng/dl) with standard deviation over a 24-hour period on Day 364 in subjects treated with Testosterone Gel, 1.62%. The x-axis represents time in hours, and the y-axis shows testosterone concentration. Dashed lines indicate the normal testosterone range between 300 and 1000 ng/dl.*

FDA Label Image

Figure-a (Image 09)

An instructional diagram titled Figure A showing the recommended application sites for testosterone topical gel. The figure illustrates the front and side views of a male torso with shaded areas on the shoulders and upper arms indicating where the gel should be applied.*

FDA Label Image

Carton (6m3d7rcc4)

Packaging label for Testosterone Gel 1.62%, a topical gel with 20.25 mg of testosterone per pump actuation, delivering 1.25 g of gel per actuation. The label indicates 68.4% v/v alcohol content and specifies it is for prescription use only. The product is manufactured and distributed by Padagis Israel Pharmaceuticals Ltd. The label includes warnings, usage instructions, and a barcode, with a multi-dose pump dispensing up to 60 actuations.*

FDA Label Image

Serialization-template.jpg (Serialization Template)

Label panel with placeholder text for serial number, lot number, and expiration date fields, indicating spaces to insert product-specific manufacturing information such as serial number (S/N), lot number, and expiration date (Exp).*

FDA Label Image

Carton 1.25 (63239rcc5)

Packaging label for Testosterone Gel 1.62%, a topical gel. The label shows the concentration 1.62% (16.2 mg/g) and states that each pack contains 30 unit-dose packets, each with 0.25 mg of testosterone in 1.25 grams of gel. The product is labeled for prescription use only and is manufactured by Padagis Israel Pharmaceuticals Ltd. The label design includes the Padagis logo and dosage instructions for topical use.*

FDA Label Image

Rx-serialization (Image 10)

A text panel with placeholders for product identification information, including serial number (S/N), lot number, and expiration date (Exp), intended for labeling a testosterone topical gel product by Padagis Israel Pharmaceuticals Ltd.*

FDA Label Image

Carton 2.5 (63265rcc5)

Packaging label for Testosterone Gel 1.62% topical gel by Padagis Israel Pharmaceuticals Ltd. The label indicates the product contains 40.5 mg of testosterone in 2.5 grams of gel per unit dose, with 30 unit-dose packets per package. The label includes directions for topical use and storage instructions.*

FDA Label Image

Serialization (Image 11)

Text panel showing placeholders for serial number, lot number, and expiration date of the testosterone topical gel product from Padagis Israel Pharmaceuticals Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.